Loading Curie Briefs...
Getting the latest healthcare news for you
Getting the latest healthcare news for you
Gout patients face a significantly higher risk of serious fractures compared to those without the condition, a large South Korean study found. But there's good news: patients who consistently took allopurinol had a notably lower fracture risk than those who didn't. The findings underscore the importance of long-term medication adherence in managing gout beyond just controlling uric acid levels.
A new retrospective study out of South Korea adds a concerning dimension to gout management — fracture risk. Analyzing data from a national health insurance database, researchers found that patients newly diagnosed with gout faced a dramatically higher risk of major osteoporotic fractures (vertebral, hip, and distal radius) compared to matched individuals without gout.
The silver lining? Adherence to allopurinol, the go-to uric acid-lowering drug, made a meaningful difference. Patients with high adherence still had elevated fracture risk compared to controls, but significantly less so than those with low adherence — suggesting that consistent treatment may help buffer some of gout's skeletal consequences.
By the Numbers:
Why it matters: Gout is often managed with a narrow focus on uric acid control, but this study signals that fracture prevention should also be on clinicians' radar. Encouraging patients to stay consistent with allopurinol could have benefits well beyond joint pain relief.
